News
ABVX
124.99
+0.36%
0.45
Weekly Report: what happened at ABVX last week (0202-0206)?
Weekly Report · 5d ago
Weekly Report: what happened at ABVX last week (0126-0130)?
Weekly Report · 02/02 09:30
Harbor Small Cap Growth Fund Q4 2025 Portfolio Performance
Seeking Alpha · 01/30 03:30
Analysts Offer Insights on Healthcare Companies: Apellis Pharmaceuticals (APLS), Ascendis Pharma (ASND) and Abivax SA Sponsored ADR (ABVX)
TipRanks · 01/26 13:30
Weekly Report: what happened at ABVX last week (0119-0123)?
Weekly Report · 01/26 09:30
Abivax CEO Dismisses Rumors of Eli Lilly (LLY) Takeover as ‘Noise’
TipRanks · 01/20 16:53
Abivax CEO responds to Lilly acquisition rumors
Seeking Alpha · 01/20 15:16
BUZZ-U.S. STOCKS ON THE MOVE-Netflix, ServiceNow, D.R. Horton
Reuters · 01/20 14:11
BUZZ-U.S. STOCKS ON THE MOVE-RAPT Therapeutics, gold miners, Critical Metals
Reuters · 01/20 12:10
Abivax CEO dismisses 'noise' around rumored Eli Lilly bid
Reuters · 01/20 11:00
BUZZ-Abivax rises as another media report feeds M&A chatter
Reuters · 01/20 08:56
U.S. Chess Champion is Bullish on these 3 New Year Stocks
TipRanks · 01/19 14:11
Weekly Report: what happened at ABVX last week (0112-0116)?
Weekly Report · 01/19 09:33
Key deals this week: Micron Technology, Worthington Steel, Boston Scientific, CrowdStrike and more
Seeking Alpha · 01/17 20:15
Kepler Capital Keeps Their Buy Rating on Abivax SA (0RA9)
TipRanks · 01/14 01:47
French Government Shoots Down Rumors Eli Lilly (LLY) Is Planning to Takeover Biotech Firm Abivax
TipRanks · 01/13 20:24
Nvidia, Eli Lilly Launch $1 Billion AI Lab To Build Meds
Benzinga · 01/13 15:37
Abivax SA Sponsored ADR (ABVX) Receives a Buy from Truist Financial
TipRanks · 01/13 03:15
Abivax: Don't Just Buy The Rumor, Buy The Fundamentals
Seeking Alpha · 01/12 17:31
U.S. Chess Champion is Bullish on these 3 Stocks – GOOG, ABVX, MP
TipRanks · 01/12 16:22
More
Webull provides a variety of real-time ABVX stock news. You can receive the latest news about Abivax S.A. through multiple platforms. This information may help you make smarter investment decisions.
About ABVX
Abivax SA is a clinical stage biopharmaceutical company focusing on the discovery, development and commercialization of anti-viral compounds and therapeutic vaccines against severe and life threatening infectious diseases. ABIVAX utilizes RNA-protein interaction interference and cytotoxic TH1 cell amplification to generate therapies to help patients clear viruses like HIV, HBV and HPV. The Company's product pipeline comprises ABX 203, which is the therapeutic vaccine candidate obtained from the Centre for Genetic Engineering and Biotechnology, Cuba (CIGB) and is intended for patients with chronic hepatitis B disease; and ABX196, the adjuvant for therapeutic vaccines, among others.